Turner Investments’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Turner Investments’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-22,500	Closed	-$62K	–	298
2016 Q4	$62K	Sell	22,500 -127,500	-85%	-$365K	0.03%	240
2016 Q3	$470K	Sell	150,000 -250,000	-63%	-$911K	0.16%	145
2016 Q2	$2.05M	Sell	400,000 -105,420	-21%	-$507K	0.64%	54
2016 Q1	$2.07M	Sell	505,420 -203,468	-29%	-$1.09M	0.56%	60
2015 Q4	$5.75M	Buy	708,888 +15,766	+2%	+$131K	1.19%	18
2015 Q3	$5.85M	Buy	693,122 +189,900	+38%	+$1.75M	1.18%	17
2015 Q2	$4.74M	Buy	503,222 +207,868	+70%	+$1.94M	0.87%	31
2015 Q1	$2.73M	Buy	295,354 +204,080	+224%	+$1.95M	0.49%	69
2014 Q4	$844K	Sell	91,274 -52,029	-36%	-$438K	0.1%	295
2014 Q3	$1.28M	Sell	143,303 -220	-0.2%	-$1.6K	0.08%	328
2014 Q2	$1.13M	Buy	143,523 +62,573	+77%	+$473K	0.05%	369
2014 Q1	$640K	Buy	+80,950	New	+$651K	0.02%	478

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Turner Investments's CORV Position: Q1 2017 in Review

Turner Investments sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2017, closing a stake of 22,500 shares — an estimated $62K sold.

Turner Investments first reported a position in CORV in Q1 2014 and held it in 12 quarters. The position peaked at $5.85M in Q3 2015. 32 funds tracked by Wall St. Rank hold CORV as of Q1 2017.

Turner Investments reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2017 after selling out during the quarter.
Turner Investments sold 22,500 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2017, an estimated $62K.
Turner Investments first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2014 and held it in 12 quarters.
Turner Investments's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $5.85M in Q3 2015.
32 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.